Many discoveries now revolutionizing the prevention and treatment of cancer can be traced back to Dartmouth—including immunotherapies for solid tumors, the integration of palliative care with cancer care, and the identification of cancer risks from environmental toxins and behaviors.
With new philanthropic support and with patients as our partners, we will leverage this hotbed of innovation and collaboration to spur advances in the discovery and delivery of cancer care and prevention as no other institution can.
Goal: $100 million
Shaping the Future of Cancer Care and Cures
Geisel seeks a transformative naming gift for the Cancer Center, as well as targeted philanthropic investments to achieve the following:
- Bring the full strength of all disciplines to bear on the problem of cancer by deepening and expanding the Cancer Center’s many collaborations across the entirety of Dartmouth’s academic and medical communities. ($31 million)
- Accelerate the development of new therapies and devices by strengthening our research and entrepreneurial infrastructure, making Geisel a preferred partner for biotechnology companies in the evaluation of new drugs and devices for cancer detection, prevention, and treatment. ($25 million)
- Liberate our most innovative faculty to conduct more high-risk, high-impact research that departs from the “safe bets” typically funded by traditional sources. ($40 million)
- Expand learning opportunities to Dartmouth students at all levels—undergraduate and graduate—using cancer as a teaching lens to explore complex interdisciplinary problems. ($4 million)
- Build on areas of excellence and innovation at Geisel that have the greatest potential to shape the future of cancer prevention, diagnosis, treatment, and care delivery. ($25 million)
Together these strategies will spur effective, personalized, and patient-centered approaches to cancer prevention, diagnosis, treatment, and survivorship—while providing a distinctly Dartmouth education to the next generation of physicians, scientists, innovators, and thought leaders.
“Because of Dartmouth’s commitment to putting patients and families first, all of our discoveries, from cancer mechanisms to cancer treatments to new ways of cancer care delivery, always have the patient at the center.”
—Steven Leach, MD, Preston T. and Virginia R. Kelsey Distinguished Chair in Cancer; Director, Cancer Center
Surgeons love to fix things. Often that means removing a tumor or repairing a joint. But for surgical oncologist Richard Barth, MD, that also means improving the entire approach for one of the most common surgeries he does: lumpectomy, removing a tumor while leaving the breast intact.